SYNDROMIC TESTING

QIAsphere Insights

Your compass for disease incidence and prevalence

Confidently navigate the ebb and flow of infectious diseases in your community – and beyond – with QIAsphere Insights. With data from your own QIAstat-Dx instruments and de-identified data from instruments around the world, track everything from pathogen diversity, to rates of co-detection, to Ct value measures. With QIAsphere Insights, the power of clinical epidemiology is in your hands.

What does QIAsphere Insights offer?

Use your epidemiology dashboard on demand

Access interactive reports of pathogen diversity, positivity rates per week, month or year, Ct value measures, co-detections and more.

Automatically create custom reports

Easily export and download a full, customized report of your data in .xls format to speed up and simplify your required reporting.

View local, regional and global data

Whether you want to see data for your institute, individual nations, a geographic region or for the entire world, it’s all available in your dashboard.

Stay in control of your testing

With the consumption report feature, get a bird's-eye view of your monthly test usage. Save on costs by only ordering what you know you'll need.

See only anonymized data

We take the security of your patient's data seriously. All data is de-identified before processing and we present it in an aggregated and anonymized manner that adheres to the highest standards of data protection, including global data privacy laws and regulations.

How can QIAsphere Insights support my work?

Refine your diagnoses

Know which diseases are common in your community throughout the year to improve your diagnostic approach.

Hone your therapeutic use

Identify trends in the prevalence of bacteria, viruses and other pathogens and use this data to guide antimicrobial use.

Rev up your research

Access automated epidemiology reports so you can focus on analyzing your data, not collecting it.

Pathogen diversity

Track the full scope of disease-causing pathogens* that exist in your community and see how their prevalence changes over time.

*Pathogen diversity is limited to the targets present on the QIAstat-Dx panels.

Positivity rates

See how positivity rates vary from week to week, month to month and year to year so you can react to outbreaks early and plan ahead for seasonal spikes in illness.

Ct values

View the median and mean Ct value measurements for different pathogens over time, and track how these measures relate to the number of positive cases.

Co-detections over time

View the top 5 most frequent pathogen co-detections over time, as well as a full breakdown of co-detections between every pathogen on a given QIAstat-Dx panel.

Global perspective

Scale up your insights – view epidemiology data for your institute and your entire geographic region. And with hundreds of QIAstat-Dx instruments connected to QIAsphere globally, you can even see aggregated, fully anonymized data from around the world.

Data shown corresponds to RSV obtained using the QIAstat-Dx Respiratory SARS-CoV-2 Panel from Nov 2022 – March 2023.

Customized .xls reports

If you’re looking for a way to expedite your epidemiology reporting, this is it. From your Insights dashboard, select only the data you want to see. Then quickly and easily export and download a full, customized report of your data in .xls format.

Useful findings from the Insights dashboard

Low-plex doesn’t cut it for respiratory infections

Our Insights dashboard shows that if you only test your patients for a few viral respiratory pathogens (Influenza A, Influenza B, RSV and SARS-CoV-2), you could be missing a huge proportion of positive cases.

Respiratory season: 38% missed with low-plex

At the peak of the 2022/2023 respiratory season, these four viruses accounted for just 62% of positive cases. That means 38% of infections would go undiagnosed without multiplex testing.

Other times of year: 71% missed with low-plex

At other times of year, these viruses made up as little as 29% of positive cases – leaving 71% of cases that would go undiagnosed without multiplex testing.

The bottom line?

With a multiplex approach, you’re less likely to miss positive cases, meaning you can provide the best possible therapeutic intervention for your patients.

A tale of two (types of) pathogens

The Centers for Disease Control and Prevention estimates that up to 50% of all outpatient antibiotic use may be unnecessary or inappropriate in selection, dose and duration (https://www.cdc.gov/antibiotic-use/data/outpatient-prescribing/index.html).

This rings true with results from our Insights dashboard for respiratory infections. In 2022, bacteria accounted for a very small percentage of positive detections, with viruses making up the vast majority.

Get even more insight with our app

Found an unexpected result in your testing and need a quick refresher on pathogen biology? Find answers fast with the Pathogen Guide, our new medical reference app. Quickly access reliable clinical information about dozens of viruses, bacteria, fungi and parasites.

Get the app

More to explore

Go beyond fast results with QIAstat-Dx

Looking for a rapid diagnostic tool that can detect and differentiate multiple pathogens at once? We have what you need.

Meet QIAstat-Dx

Prescribe strategically this year

Our Insights data shows low positivity rates for bacterial causes of respiratory infections. Explore the risks of antibiotic misuse and overuse in our recent article.

Read the article

Explore our library of webinars

Watch our most recent webinars to learn how experts have incorporated multiplex panel testing into their diagnostic approach.

Watch webinars

The QIAstat-Dx Analyzer and Panels are intended for in vitro diagnostic use.

Data is aggregated from QIAsphere-connected QIAstat-Dx instruments only. Not all QIAstat-Dx instruments are connected to QIAsphere.

Access to the QIAsphere Insights dashboard requires a QIAstat-Dx Connectivity plan. Flexible plans are available to meet your lab’s needs.

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor.